Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiology of itching

M W Greaves1, P D Wall

  • 1St. John's Institute of Dermatology, London, UK.

Lancet (London, England)
|October 5, 1996
PubMed
Summary
This summary is machine-generated.

Itching, a common skin disease symptom, is poorly understood. New research highlights how nerve pathways, histamine, and central nervous system regulation, including scratching, influence itch perception and offer therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pioneers in dermatology and venereology: an interview with Prof. Malcolm Greaves.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Cosmetics and toiletries: evaluation of efficacy, safety and quality.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
Same author

Omalizumab for chronic spontaneous urticaria: a boon for sufferers, but there are unanswered questions.

The British journal of dermatology·2015
Same author

Chronic urticaria due to autoreactivity to progesterone.

Clinical and experimental dermatology·2015
Same author

Chronic urticaria: an orphan disease for 125 years.

The British journal of dermatology·2014
Same author

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.

Allergy·2010
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Neuroscience
  • Dermatology
  • Immunology

Background:

  • Itch is a primary symptom of skin disease, yet its underlying mechanisms and neural pathways remain poorly understood.
  • The relationship between itch and pain perception is a subject of ongoing scientific debate.
  • Inflamed skin involves key mediators like histamine, released from mast cells, particularly in conditions such as chronic urticaria.

Purpose of the Study:

  • To elucidate the complex mechanisms governing itch perception in skin diseases.
  • To explore the roles of peripheral and central nervous system components in regulating itch.
  • To identify potential therapeutic targets for managing pruritus.

Main Methods:

  • Review of current understanding of nerve pathways involved in itch.

Related Experiment Videos

  • Analysis of the role of histamine, tachykinins (e.g., substance P), and cytokines (e.g., interleukin-2) in peripheral itch signaling.
  • Investigation of central nervous system mechanisms, including opioid mu-receptor pathways, in modulating itch.

    • Main Results:

    • Histamine release from mast cells is crucial in inflamed skin conditions like chronic urticaria.
    • Peripheral mediators such as substance P and interleukin-2 are significant in itch signaling.
    • Central nervous system processes, particularly involving opioid mu-receptors, actively regulate itch intensity and quality.

    Conclusions:

    • Scratching large skin areas may activate inhibitory pathways that suppress itch.
    • Understanding these regulatory mechanisms opens avenues for novel therapeutic interventions for itching.
    • Further research into itch pathways promises improved management of dermatological conditions characterized by pruritus.